Key statistics dashboard for Pasithea Therapeutics Corp. (KTTA). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions.
Stock Data
| Price | $0.49 |
| Market Cap | $16M |
| Enterprise Value | -$45.65B |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.20 |
| Price / Book | 0.07 |
| P/S | 0.00 |
| EV/EBITDA | 1958.95 |
| EV/Sales | 0.00 |
| EV/FCF | 2567.12 |
| P/FCF | -0.94 |
| Earnings Yield | -618.01% |
| FCF Yield | -108.60% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 0.00% |
| EBIT Margin | 0.00% |
| EBITDA Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | -49.49% |
| Return on Assets | -41.18% |
| Return on Invested Capital | -48.04% |
| Return on Capital Employed | -48.04% |
Financial Health
| Current Ratio | 26.25 |
| Quick Ratio | 26.25 |
| Cash Ratio | 24845.40 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 1959.66 |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -0.66 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 7.09 |
| Cash per share | 6494.64 |
| FCF per share | -2.53 |
| Tangible Book Value per share | -485.86 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Related companies: AIM · CYCN · IBO · KALA · NBY · PLRZ · QNRX
Explore sector: Healthcare · Biotechnology
More sections of KTTA: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks